← Evidence map

ArticleBlood advances2024

Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma.

Sandhya Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 38640255